JINLING PHARM. (000919)

Overview

Jinling Pharmaceutical Company Limited is a distinguished entity in China's pharmaceutical sector, focusing on the manufacturing and distribution of a broad array of pharmaceutical products and medical devices. Founded in 1998 and rooted in Nanjing, China, the company has committed itself to addressing a range of health conditions through its extensive product offerings. It stands out for its dedication to innovation and quality in providing solutions for various medical needs, along with offering medical and health care services that further underscore its role in enhancing patient care and treatment outcomes.

Products and Services

Mailuoning Injection/Oral Solutions
Designed to treat an array of vascular diseases such as thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and its sequelae, polyarteritis, acute arterial embolism of the extremities, diabetic gangrene, intravenous thrombus, and thrombophlebitis, Mailuoning injection/oral solutions represent a pivotal part of Jinling Pharmaceutical’s product line.

Ferrous Succinate Tablets
These tablets are formulated to prevent and treat iron deficiency anemia, catering to patients who suffer from this condition by providing an essential mineral supplementation that contributes to the overall blood health and functionality.

Lentinan Injection
Aimed at the treatment of malignant tumors, lentinan injections embody Jinling Pharmaceutical's foray into oncology, offering a therapeutic solution that supports the standard cancer treatment protocols and potentially improves patient outcomes.

Absorbable Gelatin Sponges
This medical device is designed for wound hemostasis, suitable for various medical situations where rapid blood coagulation and healing are paramount. The sponges absorb bodily fluids and provide a scaffold for blood clotting, aiding in the wound healing process.